{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:04:22Z","timestamp":1779771862365,"version":"3.53.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"DOI":"10.1038\/s41434-026-00622-4","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:31:22Z","timestamp":1779769882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DOCTER: a genetically encoded switchable protein module for ER\u03b1-mediated transcriptional regulation"],"prefix":"10.1038","author":[{"given":"Jinmin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8317-0608","authenticated-orcid":false,"given":"Yingke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"622_CR1","doi-asserted-by":"publisher","first-page":"36869","DOI":"10.1074\/jbc.R100029200","volume":"276","author":"JM Hall","year":"2001","unstructured":"Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem. 2001;276:36869\u201372.","journal-title":"J Biol Chem"},{"key":"622_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1152\/physrev.00024.2016","volume":"97","author":"JF Arnal","year":"2017","unstructured":"Arnal JF, Lenfant F, Metivier R, Flouriot G, Henrion D, Adlanmerini M, et al. Membrane and nuclear estrogen receptor alpha actions: from tissue specificity to medical implications. Physiol Rev. 2017;97:1045\u201387.","journal-title":"Physiol Rev"},{"key":"622_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1210\/edrv.20.3.0370","volume":"20","author":"JF Couse","year":"1999","unstructured":"Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev. 1999;20:358\u2013417.","journal-title":"Endocr Rev"},{"key":"622_CR4","first-page":"232","volume":"23","author":"PA Sanderson","year":"2017","unstructured":"Sanderson PA, Critchley HOD, Williams ARW, Arends MJ, Saunders PTK. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Hum Reprod Update. 2017;23:232\u201354.","journal-title":"Hum Reprod Update"},{"key":"622_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.beem.2015.04.008","volume":"29","author":"M Jia","year":"2015","unstructured":"Jia M, Dahlman-Wright K, Gustafsson J\u00c5. Estrogen receptor alpha and beta in health and disease. Best Pr Res Clin Endocrinol Metab. 2015;29:557\u201368.","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"622_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1043-2760(99)00177-0","volume":"10","author":"DP McDonnell","year":"1999","unstructured":"McDonnell DP. The molecular pharmacology of SERMs. Trends Endocrinol Metab. 1999;10:301\u201311.","journal-title":"Trends Endocrinol Metab"},{"key":"622_CR7","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1200\/JCO.2016.67.1487","volume":"34","author":"HS Rugo","year":"2016","unstructured":"Rugo HS, Rumble RB, Macrae E, Barton DL, Connolly HK, Dickler MN, et al. Endocrine therapy for hormone receptor\u2013positive metastatic breast cancer: American Society of Clinical Oncology guideline. JCO. 2016;34:3069\u2013103.","journal-title":"JCO"},{"key":"622_CR8","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/ng.2822","volume":"45","author":"W Toy","year":"2013","unstructured":"Toy W, Shen Y, Won H, Green B, Sakr RA, Will M, et al. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet. 2013;45:1439\u201345.","journal-title":"Nat Genet"},{"key":"622_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-021-01462-3","volume":"23","author":"JO Brett","year":"2021","unstructured":"Brett JO, Spring LM, Bardia A, Wander SA. ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer. Breast Cancer Res. 2021;23:85.","journal-title":"Breast Cancer Res"},{"key":"622_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrclinonc.2015.117","volume":"12","author":"R Jeselsohn","year":"2015","unstructured":"Jeselsohn R, Buchwalter G, De Angelis C, Brown M, Schiff R. ESR1 mutations\u2014a mechanism for acquired endocrine resistance in breast cancer. Nat Rev Clin Oncol. 2015;12:573\u201383.","journal-title":"Nat Rev Clin Oncol"},{"key":"622_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1158\/2159-8290.CD-15-1523","volume":"7","author":"W Toy","year":"2017","unstructured":"Toy W, Weir H, Razavi P, Lawson M, Goeppert AU, Mazzola AM, et al. Activating ESR1 mutations differentially affect the efficacy of ER antagonists. Cancer Discov. 2017;7:277\u201387.","journal-title":"Cancer Discov"},{"key":"622_CR12","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/ng.2823","volume":"45","author":"DR Robinson","year":"2013","unstructured":"Robinson DR, Wu YM, Vats P, Su F, Lonigro RJ, Cao X, et al. Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nat Genet. 2013;45:1446\u201351.","journal-title":"Nat Genet"},{"key":"622_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.11613\/BM.2014.035","volume":"24","author":"P Vrta\u010dnik","year":"2014","unstructured":"Vrta\u010dnik P, Ostanek B, Mencej-Bedra\u010d S, Marc J. The many faces of estrogen signaling. Biochem Med. 2014;24:329\u201342.","journal-title":"Biochem Med"},{"key":"622_CR14","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1093\/nar\/29.14.2905","volume":"29","author":"CM Klinge","year":"2001","unstructured":"Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 2001;29:2905\u201319.","journal-title":"Nucleic Acids Res"},{"key":"622_CR15","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1210\/me.2003-0044","volume":"18","author":"R O\u2019Lone","year":"2004","unstructured":"O\u2019Lone R, Frith MC, Karlsson EK, Hansen U. Genomic targets of nuclear estrogen receptors. Mol Endocrinol. 2004;18:1859\u201375.","journal-title":"Mol Endocrinol"},{"key":"622_CR16","doi-asserted-by":"publisher","first-page":"12819","DOI":"10.1074\/jbc.M709936200","volume":"283","author":"C Mao","year":"2008","unstructured":"Mao C, Patterson NM, Cherian MT, Aninye IO, Zhang C, Montoya JB, et al. A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells. J Biol Chem. 2008;283:12819\u201330.","journal-title":"J Biol Chem"},{"key":"622_CR17","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1210\/en.2005-0160","volume":"146","author":"H Chen","year":"2005","unstructured":"Chen H, Stuart W, Hu B, Nguyen L, Huang G, Clemens TL, et al. Creation of estrogen resistance in vivo by transgenic overexpression of the heterogeneous nuclear ribonucleoprotein-related estrogen response element binding protein. Endocrinology. 2005;146:4266\u201373.","journal-title":"Endocrinology"},{"key":"622_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1210\/me.2007-0297","volume":"22","author":"H Chen","year":"2008","unstructured":"Chen H, Hewison M, Adams JS. Control of estradiol-directed gene transactivation by an intracellular estrogen-binding protein and an estrogen response element-binding protein. Mol Endocrinol. 2008;22:559\u201369.","journal-title":"Mol Endocrinol"},{"key":"622_CR19","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1210\/en.2008-1148","volume":"150","author":"H Chen","year":"2009","unstructured":"Chen H, Clemens TL, Hewison M, Adams JS. Estradiol and tamoxifen mediate rescue of the dominant-negative effects of estrogen response element-binding protein in vivo and in vitro. Endocrinology. 2009;150:2429\u201335.","journal-title":"Endocrinology"},{"key":"622_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1586\/14737140.2.3.267","volume":"2","author":"JM Dixon","year":"2002","unstructured":"Dixon JM. Exemestane: a potent irreversible aromatase inactivator and a promising advance in breast cancer treatment. Expert Rev Anticancer Ther. 2002;2:267\u201375.","journal-title":"Expert Rev Anticancer Ther"},{"key":"622_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1470-2045(21)00758-0","volume":"23","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2022","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials. Lancet Oncol. 2022;23:382\u201392.","journal-title":"Lancet Oncol"},{"key":"622_CR22","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1126\/science.7792603","volume":"268","author":"M Gossen","year":"1995","unstructured":"Gossen M, Freundlieb S, Bender G, M\u00fcller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 1995;268:1766\u20139.","journal-title":"Science"},{"key":"622_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0092-8674(81)90180-X","volume":"25","author":"S Austin","year":"1981","unstructured":"Austin S, Ziese M, Sternberg N. A novel role for site-specific recombination in maintenance of bacterial replicons. Cell. 1981;25:729\u201336.","journal-title":"Cell"},{"key":"622_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mce.2003.12.005","volume":"218","author":"J Huang","year":"2004","unstructured":"Huang J, Li X, Yi P, Hilf R, Bambara RA, Muyan M. Targeting estrogen-responsive elements (EREs): design of potent transactivators for ERE-containing genes. Mol Cell Endocrinol. 2004;218:65\u201378.","journal-title":"Mol Cell Endocrinol"},{"key":"622_CR25","doi-asserted-by":"publisher","first-page":"27949","DOI":"10.1074\/jbc.272.44.27949","volume":"272","author":"MA Kuntz","year":"1997","unstructured":"Kuntz MA, Shapiro DJ. Dimerizing the estrogen receptor DNA binding domain enhances binding to estrogen response elements. J Biol Chem. 1997;272:27949\u201356.","journal-title":"J Biol Chem"},{"key":"622_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/bioengineering9020083","volume":"9","author":"S Shui","year":"2022","unstructured":"Shui S, Wang S, Liu J. Systematic investigation of the effects of multiple SV40 nuclear localization signal fusion on the genome editing activity of purified SpCas9. Bioengineering. 2022;9:83.","journal-title":"Bioengineering"},{"key":"622_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630:493\u2013500.","journal-title":"Nature"},{"key":"622_CR28","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1126\/science.1071884","volume":"296","author":"DP McDonnell","year":"2002","unstructured":"McDonnell DP, Norris JD. Connections and regulation of the human estrogen receptor. Science. 2002;296:1642\u20134.","journal-title":"Science"},{"key":"622_CR29","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1677\/ERC-09-0086","volume":"16","author":"WJ Welboren","year":"2009","unstructured":"Welboren WJ, Sweep FCGJ, Span PN, Stunnenberg HG. Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated? Endocr Relat Cancer. 2009;16:1073\u201389.","journal-title":"Endocr Relat Cancer"},{"key":"622_CR30","first-page":"3867","volume":"51","author":"AE Wakeling","year":"1991","unstructured":"Wakeling AE, Dukes M, Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res. 1991;51:3867\u201373.","journal-title":"Cancer Res"},{"key":"622_CR31","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1073\/pnas.83.8.2496","volume":"83","author":"Y Berthois","year":"1986","unstructured":"Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA. 1986;83:2496\u20132500.","journal-title":"Proc Natl Acad Sci USA"},{"key":"622_CR32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/15073","volume":"17","author":"AR Utomo","year":"1999","unstructured":"Utomo AR, Nikitin AY, Lee WH. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice. Nat Biotechnol. 1999;17:1091\u20136.","journal-title":"Nat Biotechnol"},{"key":"622_CR33","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/nar\/gni051","volume":"33","author":"G Belteki","year":"2005","unstructured":"Belteki G, Haigh J, Kabacs N, Haigh K, Sison K, Costantini F, et al. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res. 2005;33:e51.","journal-title":"Nucleic Acids Res"},{"key":"622_CR34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1681\/ASN.2005050547","volume":"17","author":"J Juhila","year":"2006","unstructured":"Juhila J, Roozendaal R, Lassila M, Verbeek SJ, Holthofer H. Podocyte cell-specific expression of doxycycline inducible Cre recombinase in mice. J Am Soc Nephrol. 2006;17:648\u201354.","journal-title":"J Am Soc Nephrol"},{"key":"622_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3389\/fmicb.2016.00485","volume":"7","author":"B Jiang","year":"2016","unstructured":"Jiang B, Zhang R, Feng D, Wang F, Liu K, Jiang Y, et al. A Tet-on and Cre-loxP-based genetic engineering system for convenient recycling of selection markers in Penicillium oxalicum. Front Microbiol. 2016;7:485.","journal-title":"Front Microbiol"},{"key":"622_CR36","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1021\/acsptsci.2c00109","volume":"5","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang Z, Xue X, Fan T, Tan C, Liu F, et al. PROTAC degrader of estrogen receptor \u03b1 targeting DNA-binding domain in breast cancer. ACS Pharm Transl Sci. 2022;5:1109\u201318.","journal-title":"ACS Pharm Transl Sci"},{"key":"622_CR37","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.cell.2016.04.040","volume":"165","author":"C Wang","year":"2016","unstructured":"Wang C, Han B, Zhou R, Zhuang X. Real-time imaging of translation on single mRNA transcripts in live cells. Cell. 2016;165:990\u20131001.","journal-title":"Cell"},{"key":"622_CR38","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1093\/nar\/gkaa906","volume":"48","author":"H Xu","year":"2020","unstructured":"Xu H, Wang J, Liang Y, Fu Y, Li S, Huang J, et al. TriTag: an integrative tool to correlate chromatin dynamics and gene expression in living cells. Nucleic Acids Res. 2020;48:e127.","journal-title":"Nucleic Acids Res"},{"key":"622_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2021.08.035","volume":"135","author":"Y Lin","year":"2021","unstructured":"Lin Y, Yao Y, Zhang W, Fang Q, Zhang L, Zhang Y, et al. Applications of upconversion nanoparticles in cellular optogenetics. Acta Biomater. 2021;135:1\u201312.","journal-title":"Acta Biomater"},{"key":"622_CR40","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1210\/endo.140.12.7179","volume":"140","author":"JM Hall","year":"1999","unstructured":"Hall JM, McDonnell DP. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 1999;140:5566\u201378.","journal-title":"Endocrinology"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00622-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00622-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00622-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:31:40Z","timestamp":1779769900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00622-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":40,"alternative-id":["622"],"URL":"https:\/\/doi.org\/10.1038\/s41434-026-00622-4","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"11 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval and informed consent were not needed, as no human or animal experiments were conducted and no identifiable data were collected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICAL APPROVAL"}},{"value":"All authors have provided their consent for the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}